Systematic (IUPAC) name | |
---|---|
7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
|
|
Clinical data | |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Registry Number | 2647-50-9 |
PubChem | CID: 12947024 |
ChemSpider | 10441497 |
Chemical data | |
Formula | C15H10BrFN2O |
Molecular mass | 333.16 g/mol |
|
|
|
Flubromazepam is the name used for a benzodiazepine derivative which was first made in 1960,[1] but was never marketed and did not receive any further attention or study until late 2012.[citation needed] It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.
Flubromazepam is currently being studied.[vague][2]
A closely related compound, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (below), also appears to have been sold under the same name.[citation needed]
See also
References
- ^ US 3136815, "Amino substituted benzophenone oximes and derivatives thereof"
- ^ Moosmann B, et al. Characterization of the designer benzodiazepines pyrazolam and flubromazepam and study on their detectability in human serum and urine samples. Institute of Forensic Medicine, Forensic Toxicology, University Medical Center Freiburg, Freiburg, Germany